View Author

Gretler, D.

( D. Gretler)


thrombocytopenia patient platelet baseline event outcome swets subs service model nadir population heparin pursuit 30 days eptifibatide incidence count table death nadir platelet count ͻ0.001 group trial ͻ100ϫ109/ therapy thrombocytopenic baseline hospitalization regression study hospitalization definition variable /severe transfusion placebo coll cardiol thrombocytopenic risk baseline characteristics service blood infusion onset califf rm downloaded january ischemic events /iiia end point circ.ahajournals.org significance stroke baseline platelet count procedure point safety case report form investigator infarction angina patient population characteristic reduction heparin therapy intervention number regression model robert heparin use research institute topol ej timing death /mi syndrome ischemic glycoprotein association califf harrington nonthrombocytopenia nadir platelet counts nonfatal mi




1 Most Recent Publications

Clinical Significance of Thrombocytopenia During a Non-ST-Elevation Acute Coronary Syndrome (Article)
McClure, M.W. Berkowitz, S.C. Simoons, M.L. Topol, E.J. Califf, R.M. Harrington, R.A. Deckers, J.W. Karsch, K. Sparapani, R. Tguttle, R. Kleiman, N.S. Berdan, L.G. Lincoff, A.M. Diaz, R. Gretler, D. Kitt, M.M.
1999-01-01